Sign in / Join Now
ETFs & Funds
Halozyme: Financing PEGPH20 Is Worth Raising Money $
Add a reply...
Latest StockTalks »
people get HALO breaking news and analysis by email alert.
Get email alerts on HALO »
Halozyme Therapeutics, Inc.
Get latest price
From other sites
Halozyme Provides Update On AbbVie Collaboration
at TheStreet (Nov 21, 2016)
Halozyme Therapeutics Reaches Analyst Target Price
at TheStreet (Nov 15, 2016)
Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types
at TheStreet (Nov 10, 2016)
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
at TheStreet (Nov 3, 2016)
First Week of June 2017 Options Trading For Halozyme Therapeutics (HALO)
at Nasdaq.com (Oct 25, 2016)